|
Transport
interrupted -- Texas A&M biologists trace cause of early
blindness to tissue defect
COLLEGE STATION -- Researchers at Texas A&M University
are shedding light on a rare form of early blindness, identifying
the cells involved and paving the way for possible therapies
to treat or even prevent what is currently an incurable disease.
The findings, funded by Fight
for Sight and the National Institutes of Health, are published
in the March 5-9 online Early Edition (EE) of the Proceedings
of the National Academy of Sciences.
Since
his post-doctoral days at Harvard University, Texas A&M
biologist Dr. Brian Perkins has been studying protein transport
within photoreceptors—the rod and cone cells that allow
organisms to detect their visual worlds—in zebrafish,
a vertebrate whose eye physiology is essentially identical
to that of a human. Recently he became intrigued by a 30-year-old
debate involving photoreceptor death—specifically, whether
it was a cause or an effect—in choroideremia, an X chromosome-linked
hereditary retinal degenerative disease that leads to blindness
in an estimated one in every 100,000 people, beginning with
severe loss of vision and night blindness as early as the
pre-teen years and progressing to complete blindness by middle
age.
Using a line of mutant zebrafish
developed by Rockefeller University’s Jim Hudspeth,
Perkins and Texas A&M biology graduate student Bryan Krock
zeroed in on a specific protein, the Rab escort protein-1
(REP1), which helps regulate intracellular traffic in the
photoreceptors as well as a neighboring tissue called the
retinal pigment epithelium (RPE). In collaboration with the
University of Western Kentucky’s Joseph Bilotta, they
observed that mutations in REP1 disrupt cellular processes
in the RPE, causing photoreceptor death as a secondary consequence.
Their results suggest therapies that correct the RPE may successfully
rescue photoreceptor loss in choroideremia and even reverse
the disease.
"For
decades, no one knew if the photoreceptors were dying because
of an internal trafficking defect or if they were dying as
a secondary consequence of problems in the RPE," Perkins
explains. "Previous research based on studies of human
tissue said it was independent of the RPE. We wanted to see
if that hypothesis was true. It turns out that it wasn’t,
but in making the wrong assumption, we found out something
even more interesting—a different way to cause photoreceptor
death."
"If
you disrupt protein transport, you kill the cell," Perkins
notes. "In this case, the transportation process in the
photoreceptors was perfectly normal, but the neighboring RPE
was defective, which is why the photoreceptors were dying."
"For
this particular disease, we now have the reason why people
go blind. If our results translate into treating humans, it
should lead to design of potential therapies. But at the very
least, it helped settle the controversy of why photoreceptors
are failing and why people go blind. Knowing the right cell
type to target is half the battle, and we’re saying
it’s the RPE, not the photoreceptor, and that the functional
gene can potentially be added back to the RPE using gene therapy."
In
addition to being small, relatively inexpensive and suitable
for large-scale genetic experiments, zebrafish make ideal
research specimens in Perkins’ eyes because they are
model systems, both for
treating human disease and for determining what’s important.
"Most
people think of mice, monkeys and other furry animals, rather
than fish, when they think of research subjects for human
diseases," Perkins says. "An advantage of zebrafish
is the ability to inexpensively perform forward genetic screens.
Using chemicals, we can induce random mutations throughout
the genome. We then search through dozens of zebrafish families
to identify mutant zebrafish with traits that resemble human
diseases. We use the screen to look for specific traits we
think are important, but we can’t pre-select the gene
that caused it."
"Rather
than starting with a gene to mutate and hoping to generate
a given trait, we select for the trait, then go find the mutated
gene that caused it. We let nature and the organism tell us
what’s important and what’s not."
Perkins
says the next steps for his laboratory involve continuing
investigation into protein transport processes and trying
to find additional zebrafish models of photoreceptor-specific
mutations that lead to additional causes of retinal degeneration
and blindness.
Contact:
Shana K. Hutchins
shutchins@science.tamu.edu
979-862-1237
Texas A&M University
|